Drug Interruption
Drug Interruption is a clinical management strategy within the domain of pulmonary toxicity management that consists of the temporary cessation of a pharmacological agent to mitigate or prevent drug-induced lung injury while preserving the potential for subsequent therapeutic re-initiation.
164
Publications
10.3K
Citations
1.2K
Authors
486
Institutions
Publications per year
2017–2026
57
164
Perioperative Management of Antithrombotic Therapy
James D. Douketis, Alex C. Spyropoulos, Frederick A. Spencer et al. · CHEST Journal · 2012 · 1.6K citations · Full text
Perioperative Management of Antithrombotic Therapy
James D. Douketis, Alex C. Spyropoulos, M. Hassan Murad et al. · CHEST Journal · 2022 · 401 citations
1–5 of 164
1.2K
7
h-index
5
h-index
3
h-index
3
h-index
3
h-index
1–5 of 1.2K
486

McMaster University
Hamilton, Canada
9 h-index
28 publications
8K citations
Harvard University
Cambridge, United States
8 h-index
29 publications
4.7K citations

Johns Hopkins University
Baltimore, United States
6 h-index
12 publications
728 citations
Massachusetts General Hospital
Boston, United States
5 h-index
22 publications
4.1K citations
Istituti di Ricovero e Cura a Carattere Scientifico
Rome, Italy
5 h-index
12 publications
639 citations
Inserm
Paris, France
5 h-index
66 publications
6.8K citations
Mayo Clinic in Arizona
Scottsdale, United States
4 h-index
20 publications
1.1K citations

University of Turin
Turin, Italy
4 h-index
14 publications
1.8K citations
1–8 of 486
5 publications · 449 citations
5
h-index
Repository · 4 publications · 98 citations
4
h-index
4 publications · 68 citations
4
h-index
4 publications · 229 citations
4
h-index
4 publications · 170 citations
4
h-index
1–5